17618-04-1

Basic information

• Product Name: 2,5-di-O-benzyl-D-mannitol
• Synonyms: 2,5-di-O-benzyl-D-mannitol
• CAS NO: 17618-04-1
• Molecular Weight: 362.423
• Mol File: 17618-04-1.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 2,5-di-O-benzyl-D-mannitol(CAS DataBase Reference)
• NIST Chemistry Reference: 2,5-di-O-benzyl-D-mannitol(17618-04-1)
• EPA Substance Registry System: 2,5-di-O-benzyl-D-mannitol(17618-04-1)

Safety Data

• Hazardous Substances Data: 17618-04-1(Hazardous Substances Data)

Upstream product

• 99096-86-3 1,3:4,6-di-O-benzylidene-2,5-di-O-benzyl-D-Mannitol 
• 10300-97-7 1,3;4,6-di-O-methylene-D-mannitol 
• 100-44-7 benzyl chloride 
• 100-39-0 benzyl bromide 
• 61490-28-6 1,3:4,6-di-O-benzylidene-D-mannitol 
• 114978-02-8 2,5-di-O-benzyl-1,3(R):4,6(R)-di-O-benzylidene-D-mannitol 
• 17618-03-0 O²,O⁵-dibenzyl-O¹,O³;O⁴,O⁶-dimethanediyl-D-mannitol 
• 69-65-8 mannitol 
• 28224-73-9 1,3:4,6-di-O-benzylidene-D-mannitol 

Downstream Products

• 153560-86-2 (2S,3S,4S,5S)-2,5-Bis-benzyloxy-1,6-dimercapto-hexane-3,4-diol 
• 98244-36-1 (S)-2-benzyloxy-1-hexadecyloxy-3-trityloxy-propane 
• 114935-12-5 (S)-2-benzyloxy-3-tert-butyldiphenylsilanyloxy-propan-1-ol 
• 114935-27-2 (R)-2-benzyloxy-3-(2,2-dimethyl-propionyloxy)-propan-1-ol 
• 114935-07-8 (S)-2-benzyloxy-3-(2,2-dimethyl-propionyloxy)-propan-1-ol 
• 114935-13-6 (S)-2-benzyloxy-1-tert-butyldiphenylsilanyloxy-3-trityloxy-propane 
• 114935-11-4 C₁₇H₁₇⁽²⁾HO₄ 
• 114935-10-3 C₁₇H₁₇⁽²⁾HO₄ 
• 114935-08-9 C₁₅H₂₁⁽²⁾HO₄ 
• 114935-09-0 C₁₅H₂₁⁽²⁾HO₄ 
• 91274-04-3 (R)-2-benzyloxy-3-trityloxy-propan-1-ol 
• 109371-30-4 (S)-2-benzyloxy-3-(toluene-4-sulfonyloxy)-propan-1-ol 
• 145454-65-5 1-O-benzoyl-2-O-benzyl-3-O-(p-methoxybenzyl)-sn-glycerol 
• 145484-35-1 Benzoic acid (R)-2-benzyloxy-3-oxo-propyl ester 

Relevant articles and documents

Drug-phospholipid conjugates as potential prodrugs: Synthesis, characterization, and degradation by pancreatic phospholipase A2

The aim of the present study was the synthesis of phospholipids containing a drug molecule instead of a fatty acid. Valproic acid and ibuprofen served as model compounds. The target molecules were synthesized either starting from sn-glycero-3-phosphocholi

Stable liposomes with aqueous-soluble medicaments and methods for their preparation

-

Platelet activating factor. Synthetic studies

-